CRL Charles River Laboratories Inte | US1598641074
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 3.923.061.110 | 3.848.254.880 | 1.94% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 12,33 | 11,10 | 11.04% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 17 | 17 | 0.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |